Clinical Trials Logo

Clinical Trial Summary

No systematic research has been done in the last 15 years on the accuracy of prenatal ultrasound of congenital heart diseases in Belgium. Nor are there any population-based studies available on this subject for Belgium. Based on the data of EUROCAT (European Surveillance of Congenital Anomalies) the investigators analyse prenatal diagnostic sensitivity of congenital heart diseases in the EUROCAT regions Antwerp (Flanders, Belgium)


Clinical Trial Description

Congenital heart defects are a leading cause of infant mortality with an incidence of 0,4-1,3% at birth. Although prenatal detection rates vary widely, morphological (structural) cardiac malformations are among the most frequently missed abnormalities by prenatal ultrasonography.

However, identifying fetal cardiac abnormalities early in pregnancy is essential. Early diagnosis allows extensive cardiac ultrasound, genetic testing and planning delivery in a paediatric-cardiac centre offering optimal neonatal care.

It also may allow the future parents to consider and decide for a termination of pregnancy in case of a severe fetal heart malformation with poor prognosis.

The investigator conducts a retrospective study on 2500 cases of congenital heart diseases over 20 years. Detailed data for this were made available by the EUROCAT Antwerp registry, a population-based database with controlled, reliable and robust data.

The study wants to reveal the prevalence and prenatal diagnostic sensitivity of congenital heart defects in the EUROCAT regions Antwerp (Flanders) and especially the evolution of the prenatal diagnostic rate over time.

In the second phase, a similar study in two adjacent regions, Hainaut (Wallonia, Belgium) and Groningen (The Netherlands) will follow.

On condition of correct statistic processing, these data will be suitable to compare the prevalence and to benchmark diagnostic rates of congenital heart defects in these three regions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04382222
Study type Observational
Source Universiteit Antwerpen
Contact Paul Ramaekers, MD
Phone +32477772234
Email paul.ramaekers1@telenet.be
Status Not yet recruiting
Phase
Start date June 1, 2020
Completion date December 2021

See also
  Status Clinical Trial Phase
Terminated NCT03616730 - NICOM in Pregnant Women With Heart Disease
Completed NCT03737006 - Coxsackie Virus in Pregnancy and Congenital Heart Disease
Not yet recruiting NCT05940363 - The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China
Completed NCT01603732 - Association Between a Mother's Exposure to "Strep Throat" and Her Baby's Developing Heart Disease N/A